|
Volumn 146, Issue 1-2, 2004, Pages 37-38
|
Revised Guidelines for Antihypertensive Treatment. What is Relevant for the General Practitioner?;Hochdruckleitlinien Überarbeitet: Was ist Praxisrelevant?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
DIHYDROPYRIDINE DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
PLACEBO;
CALCIUM CHANNEL BLOCKING AGENT;
ANTIHYPERTENSIVE THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIALYSIS;
EVIDENCE BASED MEDICINE;
GENERAL PRACTICE;
HUMAN;
HYPERTENSION;
KIDNEY FAILURE;
MEDICAL PRACTICE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRACTICE GUIDELINE;
SHORT SURVEY;
TREATMENT INDICATION;
ARTICLE;
CARDIOLOGY;
COMPARATIVE STUDY;
DIABETIC NEPHROPATHY;
DRUG COMBINATION;
ECONOMICS;
EUROPE;
GERMANY;
MEDICAL SOCIETY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
UNITED STATES;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CALCIUM CHANNEL BLOCKERS;
CARDIOLOGY;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DRUG THERAPY, COMBINATION;
EUROPE;
FAMILY PRACTICE;
GERMANY;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SOCIETIES, MEDICAL;
TIME FACTORS;
UNITED STATES;
|
EID: 0942286969
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (2)
|
References (0)
|